Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling

Author(s): Wenjian Jiang, Feng Lan, Hongjia Zhang

Journal Name: Current Stem Cell Research & Therapy

Volume 11 , Issue 7 , 2016

Become EABM
Become Reviewer


Cardiovascular cells derived from patient specific induced Pluripotent Stem Cell (iPSC) harbor gene mutations associated with the pathogenesis of inherited cardiac diseases and congenital heart diseases (CHD). Numerous reports have demonstrated the utilization of human induced Pluripotent Stem Cell (hiPSC) to model cardiac diseases as a means of investigating their underlying mechanisms. So far, they have been shown to investigate the molecular mechanisms of many cardiac disorders, such as long-QT syndrome (LQT), catecholaminergic polymorphic ventricular tachycardia (CPVT), dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), LEOPARD syndrome (LS), arrhythmogenic cardiomyopathy (ACM), Friedreich ataxia (FRDA), Barth syndrome (BTHS), hypoplastic left heart syndrome (HLHS), Marfan syndrome (MFS) and other CHD. This article summarizes the growing body of research related to modeling various cardiac diseases using hiPSCs. Moreover, by reviewing the methods used in previous studies, we propose multiple novel applications of hiPSCs to investigate comprehensive cardiovascular disorders and facilitate drug discovery.

Keywords: Congenital heart disease, induced pluripotent stem cells, inherited arrhythmia, inherited cardiomyopathy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [533 - 541]
Pages: 9
DOI: 10.2174/1574888X09666141016170856
Price: $65

Article Metrics

PDF: 32
PRC: 1